Sleep disorders interactions with obesity and type 2 diabetes

Obesity and type II diabetes are 21st century pandemia. These metаbolic disorders are in the focus of attention of various specialties: cardiologists, endocrinologists, nutritionists, therapists, and others. The high incidence of obesity and type II diabetes cardiovascular complications, such as myocardial infarction, stroke, chronic heart failure, dementia, determine the call of risk factors search. Modifiable factors may include sleep disturbances. Recent studies have revealed a connection between changes in sleep duration and metabolic disorders. However, to date, the mechanisms underlying this association have not been established. The aim of the review is to summarize existing epidemiological and experimental observations, as well as an analysis of possible pathophysiological mechanisms linking sleep duration with obesity and type II diabetes. The article considers current data suggesting a bi-directional association of sleep disorders with obesity and diabetes. Sleep disturbances are significant determinant of developing metabolic disorders. Sleep duration correction as one of therapeutic targets for cardiovascular complications of obesity and type II diabetes prevention.

1. Patel SR, Malhotra A, Gottlieb DJ, et al. Correlates of Long Sleep Duration. Sleep. 2006;29(7):881-889. DOI:10.1093/sleep/29.7.881

2. Cai H, Shu XO, Xiang YB, et al. Sleep duration and mortality: a prospective study of 113 138 middle-aged and elderly Chinese men and women. Sleep. 2015;38(4):529-536. DOI:10.5665/sleep.4564

3. Theorell-Haglow J, Berglund L, Berne C, Lindberg E. Both habitual short sleepers and long sleepers are at greater risk of obesity: a population-based 10-year follow-up in women. Sleep Med. 2014;15(10):1204-1211. DOI:10.1016/j.sleep.2014.02.014

4. Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529-537. DOI:10.2337/dc14-2073

5. Broussard JL, Ehrmann DA, Van Cauter E, et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157(8):549-557. DOI:10.7326/0003-4819-157-8-201210160-00005

6. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62. DOI:10.1371/journal.pmed.0010062

7. Bjorvatn B, Sagen IM, Oyane N, et al. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res. 2007;16(1):66-76. DOI:10.1111/j.1365-2869.2007.00569.x

8. Chaput JP, Despres JP, Bouchard C, Tremblay A. Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring). 2007;15(1):253-261. DOI:10.1038/oby.2007.512

9. van den Berg JF, Knvistingh Neven A, Tulen JH, et al. Actigraphic sleep duration and fragmentation are related to obesity in the elderly: the Rotterdam Study. Int J Obes (Lond). 2008;32(7):1083-1090. DOI:10.1038/ijo.2008.57

10. Chaput JP, Despres JP, Bouchard C, Tremblay A. The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep. 2008;31(4):517-523. DOI:10.1093/sleep/31.4.517

11. Vgontzas AN, Lin HM, Papaliaga M, et al. Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int J Obes (Lond). 2008;32(5):801-809. DOI:10.1038/ijo.2008.4

12. Xiao Q, Arem H, Moore SC, et al. A large prospective investigation of sleep duration, weight change, and obesity in the NIH-AARP Diet and Health Study cohort. Am J Epidemiol. 2013;178(11):1600-1610. DOI:10.1093/aje/kwt180

13. Marshall NS, Glozier N, Grunstein RR. Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev. 2008;12(4):289-298. DOI:10.1016/j.smrv.2008.03.001

14. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380-384. DOI:10.2337/diacare.26.2.380

15. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29(3):657-661. DOI:10.2337/diacare.29.03.06.dc05-0879

16. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414-420. DOI:10.2337/dc09-1124

17. Cespedes EM, Bhupathiraju SN, Li Y, et al. Long-term changes in sleep duration, energy balance and risk of type 2 diabetes. Diabetologia. 2016;59(1):101-109. DOI:10.1007/s00125-015-3775-5

18. Rahe C, Czira ME, Teismann H, Berger K. Associations between poor sleep quality and different measures of obesity. Sleep Med. 2015;16(10):1225-1228. DOI:10.1016/j.sleep.2015.05.023

19. Grimaldi D, Beccuti G, Touma C, et al. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care. 2014;37(2):355-363. DOI:10.2337/dc13-0933

20. Бродовская Т.О., Ковин Е.А., Баженова О.В., и др. Предикторы висцерального ожирения у Пациентов с синдромом обструктивного апноэ сна и нормальной массой тела. // Ожирение и метаболизм. — 2019. — Т. 16. — №2. — С. 29-35. [Brodovskaya TO, Kovin EA, Bazhenova OV, et al. Predictors of visceral obesity in normal weight obstructive sleep apnea patients. Obesity and metabolism. 2019;16(2):29-35. (In Russ.)] DOI:10.14341/omet97374

21. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137(1):95-101. DOI:10.1378/chest.09-0791

22. Gonnissen HK, Hursel R, Rutters F, et al. Effects of sleep fragmentation on appetite and related hormone concentrations over 24 h in healthy men. Br J Nutr. 2013;109(4):748-756. DOI:10.1017/S0007114512001894

23. Lakerveld J, Mackenbach JD, Horvath E, et al. The relation between sleep duration and sedentary behaviours in European adults. Obes Rev. 2016;17 Suppl 1:62-67. DOI:10.1111/obr.12381

24. Kronholm E, Harma M, Hublin C, et al. Self-reported sleep duration in Finnish general population. J Sleep Res. 2006;15(3):276-290. DOI:10.1111/j.1365-2869.2006.00543.x

25. Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J Appl Physiol (1985). 2005;99(1):338-343. DOI:10.1152/japplphysiol.00123.2005

26. Solomon TP, Haus JM, Kelly KR, et al. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care. 2010;33(7):1561-1566. DOI:10.2337/dc09-2021

27. Kirchner H, Osler ME, Krook A, Zierath JR. Epigenetic flexibility in metabolic regulation: disease cause and prevention? Trends Cell Biol. 2013;23(5):203-209. DOI:10.1016/j.tcb.2012.11.008

28. Febbraio MA, Hiscock N, Sacchetti M, et al. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes. 2004;53(7):1643-1648. DOI:10.2337/diabetes.53.7.1643

29. Jedrychowski MP, Wrann CD, Paulo JA, et al. Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. Cell Metab. 2015;22(4):734-740. DOI:10.1016/j.cmet.2015.08.001

30. Carey AL, Steinberg GR, Macaulay SL, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006;55(10):2688-2697. DOI:10.2337/db05-1404

31. Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagonlike peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17(11):1481-1489. DOI:10.1038/nm.2513

32. Nybo L, Nielsen B, Klarlund Pedersen B, et al. Interleukin-6 release from the human brain during prolonged exercise. J Physiol. 2002;542(3):991-995. DOI:10.1113/jphysiol.2002.022285

33. Sadagurski M, Norquay L, Farhang J, et al. Human IL6 enhances leptin action in mice. Diabetologia. 2010;53(3):525-535. DOI:10.1007/s00125-009-1580-8

34. Bostreom P, Wu J, Jedrychowski MP, et al. Faculty of 1000 evaluation for A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463-468. DOI:10.1038/nature10777

35. Kant AK, Graubard BI. Association of self-reported sleep duration with eating behaviors of American adults: NHANES 2005-2010. Am J Clin Nutr. 2014;100(3):938-947. DOI:10.3945/ajcn.114.085191

36. Berg C, Forslund HB. The Influence of Portion Size and Timing of Meals on Weight Balance and Obesity. Curr Obes Rep. 2015;4(1):11-18. DOI:10.1007/s13679-015-0138-y

37. Grandner MA, Jackson N, Gerstner JR, Knutson KL. Dietary nutrients associated with short and long sleep duration. Data from a nationally representative sample. Appetite. 2013;64:71-80. DOI:10.1016/j.appet.2013.01.004

38. Carole W, Sherry L, Taasan VC, et al. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med. 1981;71(2):240-245. DOI:10.1016/0002-9343(81)90124-8

39. Martinez-Ceron E, Fernandez-Navarro I, Garcia-Rio F. Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea. Sleep Med Rev. 2016;25:121-130. DOI:10.1016/j.smrv.2015.03.002

40. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220-229. DOI:10.1001/archgenpsychiatry.2010.2

41. Pan A, Lucas M, Sun Q, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010;170(21):1884-1891. DOI:10.1001/archinternmed.2010.356

42. Kotsis V, Stabouli S, Papakatsika S, et al. Mechanisms of obesity-induced hypertension. Hypertens Res. 2010;33(5):386-393. DOI:10.1038/hr.2010.9

43. Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011;18(1):28-41. DOI:10.1053/j.ackd.2010.10.003

44. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. Journal of Psychiatric Research. 2003;37(1):9-15. DOI:10.1016/s0022-3956(02)00052-3

45. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006;29(8):1009-1014. DOI:10.1093/sleep/29.8.1009

46. Konecny T, Kara T, Somers VK. Obstructive sleep apnea and hypertension: an update. Hypertension. 2014;63(2):203-209. DOI:10.1161/HYPERTENSIONAHA.113.00613

47. Broussard JL, Wroblewski K, Kilkus JM, Tasali E. Two Nights of Recovery Sleep Reverses the Effects of Short-term Sleep Restriction on Diabetes Risk. Diabetes Care. 2016;39(3):e40-41. DOI:10.2337/dc15-2214

48. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. DOI:10.1126/science.1241224

49. Cedernaes J, Osorio RS, Varga AW, et al. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease. Sleep Med Rev. 2017;31:102-111. DOI:10.1016/j.smrv.2016.02.002

50. Jiang Q, Zhang L, Ding G, et al. Impairment of the glymphatic system after diabetes. J Cereb Blood Flow Metab. 2017;37(4):1326-1337. DOI:10.1177/0271678X16654702